Ireland - English - HPRA (Health Products Regulatory Authority)

epax as - omega-3-acid ethyl esters 90 - capsules, soft - 1000 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - ciclosporin - capsules, soft - 10 milligram - calcineurin inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - ciclosporin - capsules, soft - 100 milligram - calcineurin inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - ciclosporin - capsules, soft - 25 milligram - calcineurin inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - ciclosporin - capsules, soft - 50 milligram - calcineurin inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - ibuprofen - capsule, soft - 400mg - anti-inflammatory and antirheumatic products, non-steroids, propionic acid derivative - for the short-term symptomatic treatment of mild to moderate pain, such as headache, acute migraine headache with or without aura, dental pain, period pain and fever and pain in the common cold.

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - sodium picosulfate - capsule, soft - 2.5 milligram(s) - contact laxatives; sodium picosulfate

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 10 mg - capsule, soft - excipient ingredients: corn glycerides; ethanol; propylene glycol; dl-alpha-tocopherol; peg-40 hydrogenated castor oil; glycerol; gelatin; titanium dioxide; hypromellose; purified water; isopropyl alcohol; cochineal; aluminium chloride; sodium hydroxide - as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. for induction and/or maintenance of remission in the nephrotic syndrome. cyclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cytostatic drugs have failed, or are not tolerated, or are considered inappropriate, and when renal function is unimpaired (see precautions). for the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with the quality of life. for the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 100 mg - capsule, soft - excipient ingredients: ethanol; iron oxide black; propylene glycol; gelatin; glycerol; peg-40 hydrogenated castor oil; titanium dioxide; corn glycerides; dl-alpha-tocopherol; hypromellose; purified water; isopropyl alcohol; cochineal; aluminium chloride; sodium hydroxide - as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. for induction and/or maintenance of remission in the nephrotic syndrome. cyclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cystostatic drugs have failed, or are not tolerated, or are considered inapropriate, and when renal function is unimpaired (see warnings). for the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with quality of life. additional indications from 11 june 1997: for the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 50 mg - capsule, soft - excipient ingredients: propylene glycol; dl-alpha-tocopherol; ethanol; gelatin; corn glycerides; peg-40 hydrogenated castor oil; titanium dioxide; glycerol; hypromellose; purified water; isopropyl alcohol; cochineal; aluminium chloride; sodium hydroxide - changes as described in the letter 23 december 1998 from b wall.